SCOTUS: Generic Makers Not Liable for Drug Design


Jun 26, 2013

The New York Times

The Supreme Court ruled on Monday that generic drug manufacturers could not be sued by patients who claim that drugs they took were defectively designed. The decision is a significant victory for the generic drug industry, but further narrows the recourse for people who are injured by such drugs.

The 5-to-4 decision overturned the verdict of a New Hampshire jury, which in 2010 awarded $21 million to a woman who developed a debilitating skin disease after taking a generic version of the pain medication sulindac. Read the full story.